Tag: multiparametric MRI

If you want your home to outsmart your neighbor’s, you can count on robotics to make you the leader on the block. Today’s smart home is equipped with robots that are trusted to mop floors, wash windows, tutor your tots, and even become your canine best friend! [Note: links to products are intended only as keep reading

Many symptoms, diseases or injuries are so clear-cut that diagnosing them is a no brainer. The body’s problem gives clear information and no guesswork is involved. Whether it’s a painful shingles rash, a rapidly swelling sprained ankle, or sudden crushing chest pain, a visit to your doctor or Emergency Department results in a rapid assessment, keep reading

More and more prostate cancer patients and their doctors are turning to Active Surveillance (AS). Data shows that for carefully chosen low risk patients, AS is a way to hold off on treatment like surgery or radiation without significantly increasing the chances of death from prostate cancer... keep reading

Before a prostate cancer patient makes a final decision to have focal laser ablation, I go over the details of MRI-guided FLA and what to expect after treatment. I remind each person that it’s important to monitor for PCa recurrence. After any focal treatment (cryo, HIFU, Focal Laser Ablation, MRgFUS, TULSA) PCa can either come back in the treatment site—called treatment failure, meaning the treatment did not destroy all the cancer at the site—or recur in a different location... keep reading

WARNING: The following information might make you wonder if your prostate gland has been exposed to harmful chemicals. Let’s start with some old news about Agent Orange. The years are 1962-70. U.S. troops are fighting in Vietnam. A plant killer called Agent Orange (named for the orange stripe on its 55- gallon storage drums) is keep reading

“For the last 40 years the prostate’s been unusual in that we’ve been interrogating men who were at risk of prostate cancer with a random needle deployment of the organ, which we don’t do in any other organ systems in relation to cancer. I think we always knew it was unreliable, and that the diagnosis was uncertain, but I think we just didn’t realize... keep reading

One of the most exciting gatherings of medical minds is the Annual Congress of the European Association of Urology (EAU). Urology Today describes it as “Europe’s biggest urological event with specialists and affiliated medical professionals gathering for a critical assessment of clinical practices and key research developments..." keep reading

From our perspective at the Sperling Prostate Center, the title question is somewhat absurd. I would respond with, “Who DOESN’T benefit the most from multiparametric MRI of the prostate?” The powerful 3T multiparametric MRI (mpMRI) that we offer provides... keep reading

Previously, we posted a recommended caution that men of African American descent discuss possible risks of going on Active Surveillance (AS) even when early clinical factors suggested they qualify for AS. Then, the authors of a 2018 paper noted that the observational studies encouraging more use of AS were largely composed of White men, raising the question of whether positive results of those studies should be applied to Black men. After reviewing studies that focused on Black men, they concluded... keep reading

When multiparametric MRI goes head-to-head against transrectal ultrasound (TRUS), it continues to demonstrate clear seniority in detecting clinically significant prostate cancer. Although conventional grayscale ultrasound can provide better results when combined with additional power using b-mode or Doppler USS, newer technologies continue to be developed. These include... keep reading